ID
12438
Description
Study documentation part: Relapse Evaluation Study short name: DIMAT MS Study Details: A 24-week, multicenter, exploratory, two arm study to assess the effect of Dimethyl fumarate on ImmuneModulatory Action on T cells in patients with relapsing remitting Multiple Sclerosis. EudraCT - No.: 2014-003481-25. Clinical Trial No.r: NCT02461069. Please document clinically significant symptoms as Adverse Events on form Adverse Events. (and also additionally as SAE if a seriousness criterion is fulfilled). Please document all Medications which are administered to treat the relapse on form concomitant medication. Please document all Study Medication dose adjustments and interruptions on form study medication.
Keywords
Versions (4)
- 11/17/15 11/17/15 - Julian Varghese
- 11/17/15 11/17/15 - Julian Varghese
- 5/28/16 5/28/16 -
- 5/28/16 5/28/16 -
Uploaded on
November 17, 2015
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Relapse Evaluation DIMAT MS Multiple Sclerosis NCT02461069
Relapse Evaluation
- StudyEvent: ODM
Description
Treatment of Relapse
Description
no treatment
Data type
boolean
Description
Plasmapheresis / Immunoadsorption
Data type
boolean
Description
enter number of cycles
Data type
integer
Description
other treatment
Data type
text
Description
Intravenous Steroid Treatment
Alias
- UMLS CUI-1
- C0149783
Similar models
Relapse Evaluation
- StudyEvent: ODM
C0808070 (UMLS CUI [1,2])
C0521091 (UMLS CUI [1,2])
C0521091 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])